×

Subcribe to Mid-day Gold with just Rs. 899 /Year

Home > News > India News > Article > Mulayam Singh Yadav remains critical being given life saving drugs says Medanta hospital

Mulayam Singh Yadav remains critical, being given life-saving drugs, says Medanta hospital

Updated on: 05 October,2022 02:12 PM IST  |  Lucknow/Gurugram
PTI |

He is being administered life-saving drugs, the hospital said

Mulayam Singh Yadav remains critical, being given life-saving drugs, says Medanta hospital

Samajwadi Party founder Mulayam Singh Yadav. File Pic


Samajwadi Party founder Mulayam Singh Yadav continues to be in the Intensive Care Unit of Medanta hospital in Gurugram and his condition remains critical, the hospital said.


He is being administered life-saving drugs, it added.



"Mulayam Singh ji is still critical and on life saving drugs, he is being treated in the ICU Medanta hospital, Gurugram, by a comprehensive team of specialists," the hospital said in a health bulletin tweeted by the Samajwadi Party's (SP) official handle.


Also Read: 1 dead, 3 injured as Gurugram building collapses during demolition

Yadav, 82, was admitted to the hospital on Sunday.

The SP patron has been under treatment at Medanta since August 22. He had also been admitted to the facility in July, sources said. 

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK